Learn, Analyse & Invest
only with
only with
+91
Download Orca
0.00
- With a market cap of N/A.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 24 05 2022 | Quarterly Results & Audited Results |
| 12 08 2022 | Quarterly Results |
| 05 11 2022 | Quarterly Results |
| 04 01 2023 | Increase in Authorised Capital |
| 04 02 2023 | Quarterly Results |
| 16 03 2023 | Rights Issue & Inter alia, to consider and approve :- 1 To discuss and if thought fit to raise capital by way of Rights Issue or other mode. 2 To take note of the resignation of Ms. Rekha Bhandari from the designation of Director. 3.To consider and approve the Appointment of Mr. Luv Sharma as an additional director of the company. 4 Any other matter with the permission of chair. |
| 29 05 2023 | Audited Results Inter alia, 1. To Consider and Approve the Audited Financial Results of the Company for the Financial year ended March 31, 2023. 2. To approve the appointment of Ms. Priti Jain and Ms. Rekha Bhandari as Non- Executive & Non-Independent Directors of the Company. |
| 10 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 12 01 2024 | Bonus issue Inter alia, to consider and approve the following matter(s):- 1. To consider and approve the fund raising in the Company through availing loan, from Rs. 413 Crore to upto Rs. 500 Crores. 2. Withdrawal of Rights Issue of equity shares of the Company. 3. Proposal of sub-division of equity shares and proposal for issuance of bonus issue of Equity Shares of the Company 4. Any other matter with the permission of chair. You are requested to kindly take the same in your records. |
| 29 01 2024 | Increase in Authorised Capital |
| 14 02 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Quarterly Results & Audited Results |
| 16 07 2025 | Inter alia, evaluate and consider fund-raising options, in one or more tranches, through issuance of equity shares and/or other eligible securities representing or linked to equity shares, including but not limited to convertible instruments, foreign currency convertible bonds (FCCBs), American Depository Receipts (ADRs), Global Depository Receipts (GDRs), qualified institutions placement (QIP), rights issue, preferential allotment, further public offering, private placement, or any combination thereof, in accordance with applicable laws and regulations. Such fund-raising, if approved by the Board, shall be undertaken in accordance with applicable laws and regulations, and shall be subject to the requisite approvals, including those of the shareholders and relevant regulatory authorities. |
| 08 08 2025 | Quarterly Results |
| 11 11 2025 | Quarterly Results |
| 04 02 2026 | Quarterly Results |
News
